Quantumzyme Corp. (OTC: QTZM), a computational enzyme engineering company, announced the publication of its research on sustainable ibuprofen synthesis in RSC Sustainability, a journal of the Royal Society of Chemistry. The peer-reviewed article, titled “In silico enzyme engineering of aldehyde dehydrogenase for eco-friendly ibuprofen synthesis” (DOI: 10.1039/D5SU00073D), details a green enzymatic process that could reduce the environmental impact of ibuprofen production.
According to the company, the research validates the feasibility and robustness of its computationally engineered enzymes for ibuprofen synthesis. The process aims to replace traditional chemical synthesis methods that rely on harsh reagents and multiple reaction steps. Quantumzyme’s approach uses digital biology and advanced enzyme design to create biocatalysts that can perform the synthesis under milder conditions, potentially improving yield and reducing waste.
“This publication is a strong validation of our vision to transform pharmaceutical manufacturing through sustainable innovation,” said Naveen Kulkarni, CEO of Quantumzyme Corp. “By combining computational enzyme engineering with green chemistry principles, we are paving the way for cleaner, smarter, and future-ready solutions for the industry.”
The announcement highlights the technology’s potential for large-scale Active Pharmaceutical Ingredient (API) manufacturing with a reduced environmental footprint. The company noted that the process aligns with global green chemistry goals and demonstrates industry readiness for scaling up.
Quantumzyme specializes in using quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to design high-performance biocatalysts. The company offers end-to-end enzyme development services, from discovery to process optimization, and aims to make eco-friendly biocatalysis the industry standard.
For full details, the article is available at RSC Sustainability: https://doi.org/10.1039/D5SU00073D. More information about Quantumzyme can be found on its website at www.quantumzymecorp.com and the Company’s profile at www.otcmarkets.com/stock/QTZM.
